Peer-reviewedCC BYJournal of clinical medicine
Longitudinal Changes in Serum Interleukin-33 Levels During Acute Psychotic Relapse and Clinical Improvement in Schizophrenia: An Admission-Discharge Study
- 1Department of Internal Medicine, Dermatology, and Psychiatry, , 38200 Tenerife, Canary Islands, Spain; (J.J.T.-C.); (E.D.-M.); (M.L.F.-L.)
- 2Department of Psychiatry, , 38320 Tenerife, Canary Islands, Spain;
- 3Unit of Physiology, Department of Basic Medical Sciences, , 38200 Tenerife, Canary Islands, Spain;
Related
- Ultra-rare coding variants in schizophrenia risk genes are associated with longitudinal phenotypic differences across psychotic disorders
- Serum Melatonin at Admission and Discharge in Schizophrenia: A Prospective Longitudinal Controlled Study
- Longitudinal white matter network reorganization after rTMS in first-episode schizophrenia: associations with sleep improvement
- Persistence of psychotic experiences and clinical outcomes in adolescents at familial high risk of schizophrenia or bipolar disorder: The Danish High Risk and Resilience Study
- Psychotic symptom burden and serum uric acid as correlates in a limited-adjustment analysis of current suicidal ideation in schizophrenia: a cross-sectional study
BibTeX
@article{morerafumero2026longitudinal,
title = {{Longitudinal Changes in Serum Interleukin-33 Levels During Acute Psychotic Relapse and Clinical Improvement in Schizophrenia: An Admission-Discharge Study}},
author = {Armando L. Morera-Fumero and José J. Tascón-Cervera and Estefania Diaz-Mesa and Silvia Yelmo-Cruz and Pedro Abreu-González and María Lourdes Fernandez-Lopez},
journal = {Journal of clinical medicine},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13666041},
note = {CC BY},
}
RIS
TY - JOUR
TI - Longitudinal Changes in Serum Interleukin-33 Levels During Acute Psychotic Relapse and Clinical Improvement in Schizophrenia: An Admission-Discharge Study
AU - Armando L. Morera-Fumero
AU - José J. Tascón-Cervera
AU - Estefania Diaz-Mesa
AU - Silvia Yelmo-Cruz
AU - Pedro Abreu-González
AU - María Lourdes Fernandez-Lopez
PY - 2026
DA - 2026/09/28
JO - Journal of clinical medicine
UR - https://europepmc.org/article/PMC/PMC13666041
SN - 2077-0383
ER -